Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Clearmind Medicine Inc., a clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems in Canada and internationally. It develops treatments for alcohol use disorders, mental health disorder, binge drinking, obesity and metabolic disorder, and eating disorders, as well as depression, binge eating, psychotherapy, and other addiction and binge behaviors. The company also develops MEAI compound which is in IND-enabling study for the treatment of alcohol use disorder; and is in pre-clinical study for treatment of obesity, weight loss, metabolic disorder, and addiction. In addition, it has a collaboration with SciSparc Ltd. to conduct a study evaluating the companies combination treatment for obesity and metabolic syndrome; Yissum Research Development Company of the Hebrew University of Jerusalem for the discovery and development of novel psychedelic-derived therapeutics to treat mental disorders; and Dr. Glitter Pty Ltd to develop and commercialize the MEAI-based alcohol substitute and ActivCrystal technology. The company was formerly known as Cyntar Ventures Inc. and changed its name to Clearmind Medicine Inc. in March 2021. Clearmind Medicine Inc. was incorporated in 2017 and is based in Vancouver, Canada. more
Time Frame | CMND | Sector | S&P500 |
---|---|---|---|
1-Week Return | 1.34% | 0.31% | -1.26% |
1-Month Return | 15.27% | 0.6% | -4.16% |
3-Month Return | 7.09% | -9.44% | -0.46% |
6-Month Return | -31.98% | -5.15% | 3.58% |
1-Year Return | 17.97% | 0.33% | 22.47% |
3-Year Return | -99.66% | 4.53% | 25.13% |
5-Year Return | -99.76% | 35.98% | 77.7% |
Oct '19 | Oct '20 | Oct '21 | Oct '22 | Oct '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | - | - | - | - | - | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":"-","profit":true}] |
Cost of Revenue | - | - | 2.57K | 113.38K | 56.34K | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":2.27,"profit":true},{"date":"2022-10-31","value":100,"profit":true},{"date":"2023-10-31","value":49.69,"profit":true}] |
Gross Profit | - | - | (2.57K) | (113.38K) | (56.34K) | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":-257200,"profit":false},{"date":"2022-10-31","value":-11337900,"profit":false},{"date":"2023-10-31","value":-5634200,"profit":false}] |
Gross Margin | - | - | (Infinity%) | (Infinity%) | (Infinity%) | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":null,"profit":false},{"date":"2022-10-31","value":null,"profit":false},{"date":"2023-10-31","value":null,"profit":false}] |
Operating Expenses | 105.28K | 233.22K | 3.68M | 8.53M | 8.74M | [{"date":"2019-10-31","value":1.2,"profit":true},{"date":"2020-10-31","value":2.67,"profit":true},{"date":"2021-10-31","value":42.06,"profit":true},{"date":"2022-10-31","value":97.61,"profit":true},{"date":"2023-10-31","value":100,"profit":true}] |
Operating Income | (105.28K) | (233.22K) | (3.45M) | (8.53M) | (8.74M) | [{"date":"2019-10-31","value":-10528300,"profit":false},{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-345299800,"profit":false},{"date":"2022-10-31","value":-853257900,"profit":false},{"date":"2023-10-31","value":-874135013,"profit":false}] |
Total Non-Operating Income/Expense | - | (233.22K) | (43.53K) | (855.54K) | (3.13M) | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-4352800,"profit":false},{"date":"2022-10-31","value":-85553690,"profit":false},{"date":"2023-10-31","value":-313041687,"profit":false}] |
Pre-Tax Income | (105.28K) | (233.22K) | (3.90M) | (9.37M) | (11.93M) | [{"date":"2019-10-31","value":-10528300,"profit":false},{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-389943400,"profit":false},{"date":"2022-10-31","value":-937005200,"profit":false},{"date":"2023-10-31","value":-1193094100,"profit":false}] |
Income Taxes | - | (385.99K) | 223.22K | 40.75K | 24.09K | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":-172.92,"profit":false},{"date":"2021-10-31","value":100,"profit":true},{"date":"2022-10-31","value":18.26,"profit":true},{"date":"2023-10-31","value":10.79,"profit":true}] |
Income After Taxes | - | 152.77K | (4.12M) | (9.41M) | (11.96M) | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":100,"profit":true},{"date":"2021-10-31","value":-2698.67,"profit":false},{"date":"2022-10-31","value":-6160.28,"profit":false},{"date":"2023-10-31","value":-7825.71,"profit":false}] |
Income From Continuous Operations | (105.28K) | (233.22K) | (3.90M) | (9.41M) | (8.62M) | [{"date":"2019-10-31","value":-10528300,"profit":false},{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-389943400,"profit":false},{"date":"2022-10-31","value":-941080600,"profit":false},{"date":"2023-10-31","value":-862083700,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":"-","profit":true},{"date":"2022-10-31","value":"-","profit":true},{"date":"2023-10-31","value":"-","profit":true}] |
Net Income | (105.28K) | (233.22K) | (4.12M) | (9.41M) | (11.96M) | [{"date":"2019-10-31","value":-10528300,"profit":false},{"date":"2020-10-31","value":-23322000,"profit":false},{"date":"2021-10-31","value":-412265200,"profit":false},{"date":"2022-10-31","value":-941080600,"profit":false},{"date":"2023-10-31","value":-1195503100,"profit":false}] |
EPS (Diluted) | - | - | (48.26) | (168.98) | (54.31) | [{"date":"2019-10-31","value":"-","profit":true},{"date":"2020-10-31","value":"-","profit":true},{"date":"2021-10-31","value":-4825.63,"profit":false},{"date":"2022-10-31","value":-16898.35,"profit":false},{"date":"2023-10-31","value":-5431.22,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
CMND | |
---|---|
Cash Ratio | 1.64 |
Current Ratio | 1.71 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
CMND | |
---|---|
ROA (LTM) | -57.95% |
ROE (LTM) | -267.90% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
CMND | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.58 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.42 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
CMND | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 1.93 |
Price/FCF | NM |
EV/R | 0.00 |
EV/Ebitda | NM |
Clearmind Medicine Inc. Common Shares (CMND) share price today is $1.51
Yes, Indians can buy shares of Clearmind Medicine Inc. Common Shares (CMND) on Vested. To buy Clearmind Medicine Inc. Common Shares from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in CMND stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Clearmind Medicine Inc. Common Shares (CMND) via the Vested app. You can start investing in Clearmind Medicine Inc. Common Shares (CMND) with a minimum investment of $1.
You can invest in shares of Clearmind Medicine Inc. Common Shares (CMND) via Vested in three simple steps:
The 52-week high price of Clearmind Medicine Inc. Common Shares (CMND) is $2.3. The 52-week low price of Clearmind Medicine Inc. Common Shares (CMND) is $0.92.
The price-to-earnings (P/E) ratio of Clearmind Medicine Inc. Common Shares (CMND) is
The price-to-book (P/B) ratio of Clearmind Medicine Inc. Common Shares (CMND) is 1.93
The dividend yield of Clearmind Medicine Inc. Common Shares (CMND) is 0.00%
The market capitalization of Clearmind Medicine Inc. Common Shares (CMND) is $6.62M
The stock symbol (or ticker) of Clearmind Medicine Inc. Common Shares is CMND